Uncategorized

Medpedia: Who gets to say what info is reliable?

Picture 4Unless you’ve been offline since last week, you know that Medpedia
has gone into public 
beta. I
have a concern about the reliability of
their model, based on my personal experience and the self-education
I’ve been doing for the past year. I want to lay out the concern, my
reasons, and a proposal.

It was a year ago that I first learned of the e-patient white paper, E-Patients: How They Can Help Us Heal Healthcare (available free in PDF or wiki), which lays out the foundational thinking for what we’re now calling participitory medicine. The Wikipedia definition of the term includes this:

"Participatory medicine is a phenomenon similar to citizen/network
journalism where everyone, including the professionals and their target
audiences, works in partnership to produce accurate, in-depth &
current information items. It is not about patients or amateurs vs.
professionals. Participatory medicine is, like all contemporary
knowledge-building activities, a collaborative venture. Medical
knowledge is a network."

In this context, I’ll lay out my concerns.

First, I understand the need for evidence and the desire to to filter out flaky assertions.

Second, I’ve often said that I'm grateful for doctors – I owe them my life.There’s no way I would have dreamed up the high-dosage Interleukin-2
treatment that saved me. Plus, that treatment was wickedly toxic when
it was first tried, and at this writing my hospital (Beth Israel
Deaconess in Boston) hasn’t had a death in 11 years. It was superb
doctors and nurses who made that happen.

However, what patients need from an online resource is reliable information on topics where they’re not experts. (The same goes for non-expert clinicians, as you’ll see below.) And my experience is that it’s an error to presume that doctors inherently have the best answer.

(Note: I did not say doctors are wrong! Read carefully. I said that presumption would be erroneous.)

For one thing, there’s the issue cited by David Servan-Schreiber, MD, in his book Anticancer: A New Way of Life.
(He’s no slouch; among other things he brought Doctors Without Borders
to the US.) He twice developed glioblastoma (a brain tumor) and beat it
with surgery, chemo and radiation. Researching how he could reduce his
odds of another recurrence, he found many papers that his colleagues
hadn’t seen – and among the colleagues he found an unconscious
attitude: “If it were real, we’d have heard about it.”

This view is understandable, but there are two massive problems:

  • There’s way too much information coming out for anyone to keep up.
    Donald Lindberge, director of the National Library of Medicine,
    explains “If I read and memorized two medical journal articles every
    night, by the end of a year I’d be 400 years behind.” (White paper, chapter 2, conclusion #6.)
  • “The lethal lag time” (Chapter 5):
    Even after research has produced a firm new result, there’s a delay
    (”latency,” in Internet engineering terms) before the information
    reaches physicians’ hands in the real world. How long a delay? Two, three, up to five years. People die during that lag time – people whose lives might depend on that latent information.

And the thing is, while doctors face incessant pressure on their
time, patients (and their suppporters) with a rare disease have all the
time in the world to go deep in their search for the latest information.

Now, you (personally) might be considering these problems in the
abstract – “How often does that happen? And besides, yeah, medicine is
hard – people do die.” But if there’s one universal I’ve learned in my
year of research, it’s this: people get radicalized when it gets personal. When it’s your life, your child, your mother, and they’re in peril, it matters whether the info you’re reading really is current, up-to-date, the best possible.

I’ll use my own condition (stage IV, Grade 4 renal cell carcinoma)
as an example. For this disease, Interleukin is the only treatment that
produces anything like a cure; any other treatment merely slows down
its progression. Yet on my ACOR.org kidney cancer listserv we
frequently encounter a new member whose local oncologist didn’t tell
him/her that Interleukin even exists as a treatment, or might have mentioned it but discouraged it.

Why?

  • Many patients say their doc gave them info that was years out of date.
    See, Interleukin doesn’t work for most patients; when I first
    researched it, different sites said the response rate was 7% or 13%.
    But my ACOR group told me it’s up to 20% – which my hospital confirmed.
    Today it’s up to 25% there – but patients whose lives are on the line are still being told it has too little chance of success to be worth the risk.
  • Regarding the risk, those doctors often cite the treatment’s
    toxicity. In my Web research I’d read that the side effects are “often
    severe and rarely fatal.” What I did NOT read, anywhere, is that a specialist hospital doesn’t have deaths anymore. (Mine hasn’t had a death in 11 years.) Those hospitals have learned how to handle the toxicity; what a patient needs to hear is get yourself to a specialist hospital.
  • But try finding that statement on any medical web site. And if you do, see if it’s expressed as directly as patients say it to each other.
  • Worse, we keep hearing that patients at one major cancer center are
    routinely not even told Interleukin exists. Some people speculate it’s
    a competitive thing, because that center doesn’t offer Interleukin and
    another center across town does. How’s that for instilling trust in
    doctors as the authoritative source? (But regardless of the reason, we
    keep hearing it happens.)
  • To return to the “when it gets personal” issue: if your mother’s
    life were at stake with this diagnosis, how would you feel if that
    option were not offered to you – for any reason? Wouldn’t you want to know every available option? I sure did.

The e-patient white paper has numerous other examples of cases where
experts said one thing and patients took matters into their own hands
and, through one method or another, developed solutions that beat what
the experts said was possible.

My question is, what would Medpedia’s editors have done in each of
those situations? And what would have been the outcome in any of those
cases if patients had submitted edits reflecting what they’d learned,
but the approved editors didn’t agree with the patient’s view?

Said differently, who will vet the vetters?


I have a suggestion, which arose Friday night in a Twitter
discussion with a clinician from another country. (Ain’t social media
great??) Among other things, she cited the good that Medpedia could do
for doctors in remote areas, or GPs researching diseases they don’t
often see. I love that! Especially for diseases like mine, where the
most current life-saving info is changing rapidly.

So I propose:

  • Patients and clinicians should be able to write comments on Medpedia articles,
    just as they can review books on Amazon or write letters to the editor
    of a medical journal. This would leverage the power of Web 2.0, just as
    it does on Amazon and countless other communities. And just as with
    blog comments, motivated participants could post as much new
    information as they want.
  • Patients should be able to mark an article as being helpful or not, as on Amazon: Amazonwasthishelpful-1
  • This would give the editors feedback on whether their lay readers found the resulting article useful.
  • Clinicians should be able to do the same, assessing the piece’s usefulness from a clinician’s perspective.

Articles would thus have publicly visible feedback to the editors, from both patients and clinicians. (See Amazon readers’ feedback
on reviews of Servan-Schreiber’s book.) Both groups, clinicians and
patients, would be able to add content of their own; and people in need
could see which pieces others had found useful:

Amazonfoundthishelpful

As shown in this example, reviewers (and probably clinicians and
editors) would eventually gain their own reputations in the community
as highly useful people. (This example happened to contain an Amazon
“Top 100 Reviewer.”) Many Web 2.0 observers have noted that reputation
has become a key factor in the success of sites like Amazon and eBay.

What do you think? Could an approach like this address the concerns I expressed above?

Some people have said it’s simply not viable for approvals to be
limited to doctors, and others have conversely said it’s unrealistic to
think patient feedback could be authoritative. Isn’t there room for
participation, for mutual contribution?

Whatever approach you want, who will vet the vetters?

e-Patient Dave, also known as Dave DeBronkart, is our favorite e-Patient. He writes on healthcare, web 2.0 technologies and related issues on the e-Patients blog and also his own personal blog, the New Life of e-Patient Dave. THCB's Matthew Holt interviewed him recently in this podcast

Livongo’s Post Ad Banner 728*90

Categories: Uncategorized

Tagged as:

4
Leave a Reply

4 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
3 Comment authors
Deron S.e-Patient DaveMichael Segal MD PhD Recent comment authors
newest oldest most voted
Deron S.
Guest

Dave – There are simply too many sources of information out there, which causes a massive duplication of effort. We need only one source, with contributions by all stakeholders. This piecemeal, fragmented approach is inefficient.

Michael Segal MD PhD
Guest

If posting here is considered a “cross-post”, then people are less likely to do so. Perhaps it would be best to indicate in the article whether comments should go here or to the first appearance of an article elsewhere (with a suitable link).
I reworked my earlier post to fit into the discussion and posted it on the original article.

e-Patient Dave
Guest

Thanks for the cross-post. There’s a slew of comment (vigorous useful dialog) on the original post over on the e-patient blog http://is.gd/ktNa.
My screen shots illustrating the proposed ratings didn’t come through here. I don’t know if they can be added, but until/unless, please have a look at them on the original post.

Michael Segal MD PhD
Guest

There is indeed a crucial role for people who have the disease. One gets the best of both world when that person is a physician, and bring both the patient and the medical perspective. Examples include Dr. Jacob O Levitt’s article on hypokalemic periodic paralysis (http://www.translational-medicine.com/content/6/1/18) and my article on asthma (http://segal.org/asthma/). One gets close to this with a non-physician who gets very well informed on a disease. This occurs on many listservs, and such individuals often get special access to the medical experts and become a conduit for information flowing in both directions. If I were running Medpedia I’d… Read more »